Purple Biotech Ltd
PPBT
$0.80
-$0.01-1.43%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -- | 63.58% | 44.65% | 23.12% | |
| Total Depreciation and Amortization | -- | -5.58% | -2.51% | -0.51% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -477.71% | -463.17% | -248.15% | |
| Change in Net Operating Assets | -- | -1,681.02% | -417.32% | 490.00% | |
| Cash from Operations | -- | 27.89% | 9.51% | 7.46% | |
| Capital Expenditure | -- | -- | 100.00% | 110.00% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | 100.00% | 100.00% | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -97.08% | -97.85% | -93.98% | |
| Cash from Investing | -- | -96.33% | -97.50% | -92.95% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -8.93% | -5.99% | -5.42% | |
| Issuance of Common Stock | -- | 401.41% | 99.08% | -6.14% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -121.71% | 1,423.08% | 1,603.32% | |
| Cash from Financing | -- | 24.32% | 448.07% | 328.16% | |
| Foreign Exchange rate Adjustments | -- | -107.41% | -51.69% | -61.54% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -1,210.17% | -339.85% | -434.11% | |